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a b s t r a c t
Objective: Presentation of the own experience in the treatment of ischemic stroke using
endovascular methods of simultaneous evaluation of their effectiveness and safety.
Materials and methods: The retrospective study involved a group of 18 patients hospitalized in
2005–2012 who were treated with intraarterial thrombolysis and mechanical thrombectomy.
Overall there were 24 procedures performed. The investigated group consisted of seven
(38.89%) women and 11 (61.11%) men. The average age of the patients was 60 years (SD  17,
median – 60 years).
Results: In 62.50% of cases (n = 15) the effect of revascularization has been achieved and
another 12.50% of cases (n = 3) recanalization was achieved only partially. Only in 25% of
procedures (n = 6) failed to achieve recanalization of the artery (TICI ≤ 1). The highest
percentage of recanalized arteries were obtained by following the procedure of thrombolysis
targeted – 69.24% (TICI ≥ 2b). In the case of mechanical thrombectomy total patency
(TICI ≥ 2b) was 54.55%. The average duration of treatment (operation) is 157 min. After 30
days successful result of the neurological status was achieved in 57.14% of patients (n = 8).
Full return to independent functioning as deﬁned within 3 months after the surgery
(mRS ≤ 2) reached 57.14% of patients (n = 8).
Conclusion: Studies suggest that endovascular techniques are effective and safe in the
treatment of ischemic stroke. Greater efﬁciency is characterized by intraarterial thromboly-
sis. Patients who were treated endovascular improved signiﬁcantly.
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Stroke is the third leading cause of death and a major cause of
disability in adults. Annually in our country due to stroke
hospitalized is about 60 000 of people. The incidence of stroke
in Poland is 177 cases per 100 000 men and 125 cases per
100 000 women [1]. In subsequent years, the number of
patients hospitalized with acute stroke may increase consid-
erably, that is why it is crucial to develop new treatments for
this disease.
Recanalization of occluded artery is strongly associated with
improved functional outcomes and reduced mortality [2].
Treatment of the acute ischemic stroke includes two possible
methods of therapy: medication, mainly intravenous throm-
bolysis and endovascular treatment – intraarterial thrombolysis
and mechanical thrombectomy. Intravenous thrombolytics
(recombinant tissue plasminogen activator (rt-PA)) adminis-
tered within 4.5 h after the onset of symptoms is standard
procedure of treatment acute ischemic stroke [3,4]. The method
of intravenous thrombolysis has a low percentage restoration
of cerebral arteries patency [5,6]. Using endovascular methods
such as: intraarterial thrombolysis and mechanical thrombect-
omy, extends the therapeutic window and allows to achieve
larger number of successful recanalization [2,7,8].
The aim of this study (research) was to establishment the
efﬁcacy and safety of the endovascular management of stroke
using endovascular techniques: intraarterial thrombolysis and
mechanical thrombectomy.
2. Materials and methods
2.1. Patients
The retrospective study involved a group of 18 patients
hospitalized in 2005–2012 who were treated with intraarterial
thrombolysis and mechanical thrombectomy. In all cases
assessed risk factors of stroke, the results indicate that the
most common cause occurring in 66.67% of cases (n = 12), is
hypertension. On further places there were found coronary
artery disease, hyperlipidemia and diabetes (Fig. 1).
Overall 24 procedures were performed. Intraarterial throm-
bolysis was performed in 54.17% (n = 13) and mechanicalFig. 1 – Risk factors of stroke.thrombectomy was carried out in 45.83% (n = 11) interventions.
The investigated group consisted of 7 (38.89%) women and 11
(61.11%) men. The average age of the patients was 60 years
(SD  17; median 60 years; range 26–84 years).
Arterial occlusion refers to various cerebral arteries. Most
frequently (22.22%) obliteration involved middle right cerebral
artery. Subsequently, occlusion occurred in the basilar artery
and the left middle cerebral artery (Table 1).
2.2. Conditions for being qualiﬁed to the procedure
To evaluate neurological deﬁcit in patients with ischemic
stroke National Institutes of Health Stroke Scale (NIHSS) has
been used. The assessment of the neurological status before
the surgery was performed in the emergency room. After-
wards, depending on the availability of diagnostic methods,
the patients were mainly examined by using TK (n = 14), angio-
CT (n = 13) and DSA (n = 8) (Fig. 2). First of all, CT was performed
to patients with suspected stroke, to exclude intracerebral
hemorrhage, subdural and epidural hematoma, and to conﬁrm
ischemia and determine the extent of ischemic damage.
Angio-CT conducted for the identiﬁcation and location of the
occlusion. One patient underwent MR-DWI. All inclusion/
exclusion criteria that were used to qualify for the endovas-
cular treatment are shown in Tables 2 and 3.
2.3. Devices and description of the procedure
2.3.1. Intraarterial thrombolysis
 Invasive technique of the treatment of acute ischemic
stroke.
 The time window for this technique is up to 6 h from the
onset of symptoms.
 It involves the direct introduction of ﬁbrinolytics to the clot
within the obstructed vessel.
 This causes a local increase of the ﬁbrinolytics concentration
which is high enough to dissolve the clot, while maintaining
low systemic concentrations. This is effective in preventing
side effects.
 Medications: rt-PA dose <0.9 mg/kg (approximately 50 mg).
Course of treatment: surgery was performed under general
anesthesia. At the beginning of the procedure there was a
venipuncture of the femoral artery on the right side and the
catheter was introduced by the Seldinger method. Then, the
contrast media administered to show the obstructed cerebralTable 1 – The most common location of obstruction.
Location Number %
Right middle cerebral artery (MCA R) 6 22.22
Basilar artery (BA) 5 18.52
Left middle cerebral artery (MCA L) 5 18.52
Right internal carotid artery (ICA R) 3 11.11
Left vertebral artery (VA L) 3 11.11
Right anterior cerebral artery (ACA R) 2 7.41
Superior cerebellar artery (SCA R) 1 3.70
Left internal carotid artery (ICA L) 1 3.70
Right posterior cerebral artery (PCA R) 1 3.70
Fig. 2 – Diagnostic methods before the treatment. (A) CT scan: hyperdense change in the course of the M2 segment of the right
middle cerebral artery. (B) CT scan: occlusion in the course of the M2 segment of the right middle cerebral artery. (C) CT
angiography: occlusion in the course of the M2 segment of the right middle cerebral artery. (D) MR T2 sequence: ischemic
stroke of the brain stem.
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microguidewire and microcatheter was introduced whose end
was placed in the proximal part of the thrombus. Rt-PA was
administered at a right dose and the thrombus was penetrated
by the microguidewire. Continuous observation during throm-
bus dissolution treatment was carried out using the DSA.
During the intervention, Heparin solution in saline is used
for permanent washing of the catheter and microcatheters.
2.3.2. Mechanical thrombectomy
2.3.2.1. Solitaire FR device.
 Mechanical thromboectomy stent used for the treatment
of ischemic stroke.
 This allows immediate restoration of ﬂow through the
occluded vessel and by expansion of it above the thrombus
there is possibility to remove the clot. Therapeutic time window is up to 8 h for the front part and
up to 15 h for the back part of the circulation from the ﬁrst
symptoms.
Course of treatment: The procedure was performed under
general anesthesia. The procedure was performed with the
venipuncture of the right femoral artery, catheter was
introduced using the Seldinger method. Then, the contrast
media was administered to visualize the location of obstruc-
tion. Stent Solitaire FR was depressurized above the thrombus
without complete releasing. Stent was extended for 1–2 min,
then was gently pulled out of the body through a guiding
catheter and thrombus was removed. The aim of the
angiography control was to assess recanalization and conﬁr-
mation of the reperfusion. During the intervention, heparin
solution in saline is used for permanent washing of the
catheter and microcatheters.




1. The clinical diagnosis of acute ischemic stroke (exclusion of
cerebral hemorrhage on CT).
2. The precise time of onset of symptoms of the current stroke
and the opportunity to start thrombectomy, time frame: up to
8 h for the stroke from the frontal circle and up to 15 h for
the stroke from posterior circle of vascularity.
3. Age over 18 years.
4. Conﬁrmed by Angio-CT, and then subtraction angiography
(DSA) obstruction of the large arterial trunk (ICA, MCA-M2
segment, VA, BA, PCA).
5. Ineffectiveness of the intravenous thrombolysis or the
failure to accomplish the inclusion criteria.
6. Ruled out the existence of other causes of the neurological
deﬁcit or causes which may mask the stroke (e.g.
hypoglycemia, state after seizure, metabolic
encephalopathy, conversion, etc.).
7. Consent to treatment.
II. Exclusion criteria:
1. Inability to clarify the time of onset of the symptoms.
2. Rapid resolution of the neurological symptoms before the
treatment.
3. Minor neurological symptoms (NIHSS <5 pts.).
4. Allergy to radiographic contrast agents in a history.
5. Reported earlier hemorrhagic diathesis.
6. Reported earlier coagulation factors deﬁcit.
7. Conﬁrmation of the intracranial hemorrhage on CT scan
or MRI.
8. A signiﬁcant mass effect on CT scan with the shifting brain
structures to the opposite side or area hipodensyjny covering
>1/3 of the area of the middle cerebral artery vascularization.
9. Suspicion of subarachnoid hemorrhage.
10. Suspected presence of the vascular malformation or
aneurysm MRI or CT.
11. A history of intracranial hemorrhage or suspected
intracranial hemorrhage.
12. Previous stroke or serious head injury within the last
3 months.
13. Damage to the CNS in a history (cancer or a history of
surgery within the skull or spine).
14. INR > 3.0, also oral anticoagulant therapy.
15. The use of heparin within 48 h before the stroke and APTT
two times longer than the upper normal limit.
16. Thrombocytopenia < 30 000/mm3.
17. Hypo- or hyperglycemia (<50 mg/dl or >400 mg/dl).
18. Systolic blood pressure >185 and diastolic blood pressure
>110 mmHg, despite of intensive lowering it.
19. Puncture an artery or a large vein in a place impossible to
press in the last 7 days
20. Recent history of external heart massage or childbirth
(within the last 10 days).
21. Myocardial infarction within the last 3 months.
22. Major surgery, a large injury or bleeding from the
gastrointestinal tract or urinary tract during the last 3 months.
23. Existing or recently severe and life-threatening bleeding.
24. Severe liver diseases (e.g. liver failure, cirrhosis, portal
hypertension, active inﬂammation) or acute pancreatitis.
25. Pregnant or lactating women.
26. Expected life time less than 3 months for the reasons other
than the current stroke.
The patient should not be treated if the points 1–6 of part I are
marked NO, or in part II are marked YES.




1. The diagnosis of acute ischemic stroke.
2. The precise time of onset of symptoms and the ability to
start an intravenous infusion of rt-PA up to 6 h of symptom
onset (3 h intravenous treatment and 6 h – treatment with
intra-arterial).
3. Age 18–75 years.
4. Ruled out the existence of the other causes of the
neurological deﬁcit, i.e. intracerebral hemorrhage, or other
reasons that may mask the stroke (CT and/or MRI).
II. Exclusion criteria
1. Rapid resolution of the neurological symptoms.
2. Minor neurological symptoms, such as: small sensory deﬁcit.
3. Inability to clarify the time of onset of symptoms.
4. Occurrence of the seizures.
5. Suspicion of the subarachnoid hemorrhage.
6. Recent myocardial infarction.
7. Current treatment with oral anticoagulants or heparin
intravenously with abnormal values of INR and APTT (in terms
of standards as for untreated, e.g. INR > 1.7, PT > 15 s).
8. Thrombocytopenia < 100 000/mm3
9. Hypo-or hyperglycemia with the values that the neurological
symptoms may occur (<50 mg/dl or >400 mg/dl).
10. Systolic blood pressure >185 mmHg and diastolic blood
pressure >110 mmHg at the beginning of the treatment, in
spite of the administration of 1–2 doses of 10 mg i.v. labetalol.
11. Disorders of blood coagulation or platelet function
(excluding patients receiving antiplatelet drugs).
12. Arterial puncture in a place impossible to press in the last
7 days.
13. Recent history of external heart massage within the last
10 days.
14. Major surgery, a large injury or bleeding from the
gastrointestinal tract or urinary tract during the last 3 months.
15. Gastric ulcer disease in the past 3 months, esophageal
varices.
16. Previous stroke or serious head injury within the last
3 months.
17. A history of intracranial hemorrhage.
18. A history of CNS surgery.
19. Hemorrhagic diathesis, existing or previous severe
hemorrhage.
20. Hemorrhagic retinopathy (e.g. in diabetes)
21. Dissecting aneurysm of the aorta or suspecting it,
abnormalities of the arteries or veins development.
22. Severe liver disease (including: liver failure, cirrhosis, portal
hypertension, active hepatitis).
23. Women of childbearing period (excluding the states where
there is certainty of the impossibility of getting pregnant,
such as sterilization).
24. Lactating women.
25. Other life-threatening disease of the patient (e.g. malignant
cancer), which can lead to death of a patient within a few
months.
26. Occurrence of the intracranial hemorrhage on CT scan or
MRI.
27. Hypodense lesions involving >33% of the territory of
vascularization MCA (hyperdense changes in MRI-DWI).
28. The suspected presence of vascular malformation, or
aneurysm in MRI or CT.
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 Device, specially designed to remove the clot mechanically.
 It works in two ways: ﬁrst way is based on the fragmentation
of thrombus, which fragments are aspirated, what protects
the catheter from plugging or circumferential displacement
of these fragments and the second way relies on the direct
removal of the embolus with balloon stopping ﬂow in the
vessel for a while.
 It consists of three main parts: the catheter reperfusion,
separator and thrombus removal ring.
 All elements can be used with a catheter-6-Fr.
 The aspiration pump generates underpressure 20 in/Hg.
Course of treatment: The procedure was performed under
general anesthesia. The procedure was performed with the
venipuncture of the right femoral artery, catheter was
introduced using the Seldinger method. Reperfusion catheter
was placed under the proximal end of the thrombus using a
catheter guiding. After removal the guiding catheter the
separator was introduced, which crushed the thrombus and
its fragments aspirated by the underpressure generated by the
aspiration pump. During the intervention, heparin solution in
saline is used for permanent washing of the catheter and
microcatheters.
2.4. Evaluation of the efﬁciency and safety of treatment
After surgery, angiography DSA was performed (Figs. 3 and 4).
Angiograms were analyzed by a radiologist. The effectiveness
of cerebrovascular recanalization was assessed by the TICI
scale (thrombolysis in cerebral infarction) (Table 4). The aim of
treatment was to achieve the level of ≥2b [9].
After treatment imaging was performed: CT/MR (24–36 h),
which aimed to detect potential complications of endovas-
cular procedures, such as: perforation of the vessel; dissection
of the vessel wall; embolization of another vessel, that was
mentioned in the procedure; symptomatic intracranial hem-
orrhage (≥4 points NIHSS or later death); complications at the
injection site (groin) requiring surgical intervention or trans-
fusion of blood products [10].
Neurological deﬁcits in patients with ischemic stroke were
determined on the basis of the National Institutes of Health
Stroke Scale (NIHSS). The neurological examination was
conducted immediately after the treatment and then 24 h, 7
days, and 30 days after the treatment. An NIHSS score of 0, 1
point or an improvement of ≥10 points was deﬁned as the
successful outcome of the therapy and reduction of neurolog-
ical symptoms. The degree of disability of patients was
determined 3 months after the surgery with the modiﬁed
Rankin scale (mRS). mRS at 3 months of ≤2 was deﬁned as the
absence of disability.
3. Results
In the study group, consisting of 18 patients, have been
performed 24 interventions of targeted thrombolysis and
mechanical thrombectomy. Four patients (22.22%) required
two stages of the treatment process and one patient (5.56%)underwent three interventions. In 12 cases the duration of
the surgery has been measured and the time of onset of stroke
symptoms by the end of the surgery. The average duration
of procedure is 157 min (SD  57; median 158 min). The longest
surgery lasted 250 min, and the shortest 55 min.
The time between the ﬁrst symptoms of stroke and the end
of the procedure was from 265 to 1170 min with the average
time 491 min (SD  240; median 415 min).
In 62.50% of cases (n = 15) the effect of entire revasculariza-
tion has been achieved and in another 12.50% of cases (n = 3)
only partial recanalization has been achieved. Only in 25% of
procedures (n = 6) recanalization of the artery has been failed
(TICI ≤ 1). The highest percentage of recanalized arteries was
obtained by following the procedure of intraarterial thrombol-
ysis – 69.24% (TICI ≥ 2b). In the case of mechanical thromb-
ectomy total patency (TICI ≥ 2b) was restored in 54.55%. The
effect of partial revascularization (TICI = 2a) gained in 15.38%
of cases of intraarterial thrombolysis and mechanical thromb-
ectomy in 36.36%. Artery patency failed (TICI ≤ 1) in 15.38% of
cases of intraarterial thrombolysis and 9.10% of mechanical
thrombectomy. The differences in results are statistically
signiﬁcant ( p < 0.001) (Fig. 5).
Neurological examinations were performed with 17
patients. Neurological deﬁcit was determined by using the
scale of the National Institutes of Health Stroke Scale (NIHSS)
and compared with the results obtained before the treatment.
During the patients' hospitalization there were two deaths.
First death occurred 6 days after, and the second one 8 days
after the surgery. Additionally, in one case, we do not have the
results of the patient's neurological examination, which was
carried out 30 days after the surgery. For this reason, the
frequency of the improvement of the neurologic status for
NIHSS scale was based on the results of carried out
neurological examination. This examination has been referred
to group of 16 patients – 7 days after the surgery, and to group
of only 14 patients – 30 days after the surgery.
Immediately after the surgery none of the patients
presented reduction in neurological symptoms. In examina-
tion performed 2 h after the procedure, neurological changes
allow for a successful evaluation of the outcome of the therapy
was found in 17.65% (n = 3) cases. The next assessment of the
neurological status was made on the ﬁrst day after the surgery.
In this case, a successful result was obtained with 11.76%
(n = 2) patients. On the seventh day successful result of the
neurological status was achieved with 31.25% (n = 5) patients,
and on the 30th day with 57.14% (n = 8) patients (Fig. 6).
Comparing the results of evaluation patients' neurological
status 30 days after the surgery, with the results of recanaliza-
tion artery, appears that revascularization brings improvement
in the neurological status in 66.67% of the cases. However in
the patients' group with no or only a partial restoring patency
of the artery, that improvement is only in 40% of the cases.
In addition, before the surgery 17 patients had the
evaluation of the functioning state, using the Rankin scale,
and 14 patients were able to make a further assessment after
90 days of the treatment. Before performing cerebral artery
recanalization with 23.53% of patients (n = 4), the result
indicated the entire functionality (mRS ≤ 2). However, three
months after the surgery mRS ≤ 2 reached 57.14% of patients
(n = 8).
Fig. 3 – (A) Digital subtraction angiography before treatment: occlusion of the right middle cerebral artery. (B) Digital
subtraction angiography after intraarterial thrombolysis: flow through the right medial cerebral artery, visible microcatheter
in the right internal carotid artery. (C) Digital subtraction angiography before mechanical thrombectomy: occlusion of the
right middle cerebral artery. (D) Digital subtraction angiography after mechanical thrombectomy: flow through the right
medial cerebral artery, visible microcatheter in through the right medial cerebral artery. (E) Digital subtraction angiography
before mechanical thrombectomy: occlusion of the right medial cerebral artery. (F) Digital subtraction angiography after
mechanical thrombectomy: flow through the right medial cerebral artery.
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 4 9 ( 2 0 1 5 ) 8 1 – 8 986
Fig. 4 – (A) CT angiography: occlusion of the basilar artery. (B) CT angiography control after surgery: flow through the basilar
artery. (C) Digital subtraction angiography before mechanical thrombectomy: occlusion of the basilar artery. (D) Digital
subtraction angiography after mechanical thrombectomy: flow through the basilar artery. (E) CT angiography control after
surgery: flow through the basilar artery. (F) Embolic cloth obtained after mechanical thrombectomy.
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The aim of treatment of acute ischemic stroke is the rapid
restoration of ﬂow in an occluded vessel. Rapid recanalizationassociated with the improved clinical status of the patient and
a reduction in mortality [2]. Ischemic stroke can be treated in
two ways: pharmacological – intravenous thrombolysis and
endovascular treatment – mechanical thrombectomy and
intraarterial thrombolysis. The standard method of treatment
Fig. 6 – Assessment of improvement of neurological status
by NIHSS scale.
Table 4 – TICI scale.
0 No perfusion
1 Penetration with minimal
perfusion
2a Only partial ﬁlling (<2/3)
2b Complete ﬁlling, slower than
normal
3 Complete perfusion
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 4 9 ( 2 0 1 5 ) 8 1 – 8 988is intravenous thrombolysis, the therapeutic window of this
method is up to 4.5 h. Intravenous thrombolysis method is
characterized by low efﬁciency [5]. The use of endovascular
methods extends the therapeutic window up to 6 h for
targeted thrombolysis and up to 15 h for mechanical thromb-
ectomy [11,12].
Our work shows that there is an alternative for patients in
whom intravenous thrombolysis was ineffective or for those
who do not fulﬁll the eligibility criteria for it.
Patients with acute ischemic stroke subjected with endo-
vascular treatment (intra-arterial thrombolysis and mechani-
cal thrombectomy) a high percentage of recanalization at the
level of 62.50% without a concomitant increase in bleeding
complications was observed. The clinical condition of the
patients according to the scale NIHHS was improved up to
66.67% of total revascularization and in 40% of cases with
partial patency vessel or the lack of recanalization.
Patients, who were embraced by target thrombolysis
treatment achieved complete (TICI ≥ 2b) or partial (TICI = 2a)
restoration of ﬂow in 84.62% of cases. In this study the MELT
gives a partial or total vascular patency with 73.7% of patients
[13]. However, in this case, except for using guidewire
mechanical techniques were not used to restore the ﬂow. In
69.24% of cases complete patency (TICI ≥ 2b) vessels using
targeted thrombolysis has been achieved. This result is similar
to what was obtained PROACT II study [14,15].
In our thesis, of effective ﬂowing, we used both techniques
of mechanical thrombectomy achieved complete or partial
patency vessels in 63.65% of patients. High efﬁciency of
Penumbra Set has been conﬁrmed in a study Penumbra Pivotal
Stroke Trial [16]. The study SWIFT found a better long-term
effect of patients' treatment, faster, more effective and safer
recanalization with Solitaire FR stent comparing with MERCI
Set [17].
In numerous reports to assess the obtained ﬂow in patent's
vessels with targeted thrombolysis an adapted classiﬁcation ofFig. 5 – The effectiveness of cerebral artery recanalization.the thrombolysis in myocardial infarction (TIMI) was used. In
2003 a speciﬁc intracranial cerebral circulation classiﬁcation
thrombolysis in cerebral infarction (TICI) was suggested,
which was used to assess recanalization in our publication
[9,18].
Evaluation of the degree of disability was based on the
modiﬁed Rankin scale. Before endovascular treatment 23.53%
of the patients score indicated a state of able-bodied (mRS ≤ 2).
However, after 90 days of the treatment mRS ≤ 2 reached
57.14% of the patients, which proves almost 2.5-fold reduc-
tions in disability. These results are similar to results reported
by several centers for various endovascular stroke therapy
[19–23]. Before the endovascular treatment 76.47% of the
patients score indicated a state of disability (mRS > 2).
There are reports of more post-surgery complications and
increased mortality after application of invasive methods as
compared to intravenous tPA [10]. However, our results show
that through appropriate inclusion criteria and combination
therapy it is possible to reduce the risk of life-threatening
complications at a satisfactory therapeutic level.
The main restriction in our study is the lack of a control
group and the small size of the study group. Therefore, our
conclusions concerning safety and effectiveness of the
procedure are limited.
5. Conclusion
The study showed that endovascular techniques are effective
and safe in the treatment of ischemic stroke. The greater
effectiveness is more characteristic for intraarterial thrombol-
ysis than mechanical thrombectomy. Patients' condition, who
were treated by endovascular technique was signiﬁcantly
improved. The main limitation of the results was the small
patients' number, that's why our conclusions regarding the
safety and efﬁcacy of these methods do not reﬂect this
condition in the population.
Currently, there is no doubt that a certain group of patients
with ischemic stroke can certainly beneﬁt from the use of
endovascular procedures. We should always remember to
take into account of such treatments when we deal with
patients who suffer from stroke.
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